Literature DB >> 12824177

Activation of 5'-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite.

Ming-Hui Zou1, Xiu-Yun Hou, Chao-Mei Shi, Stacy Kirkpatick, Feng Liu, Mitchell H Goldman, Richard A Cohen.   

Abstract

AMP-activated kinase (AMPK) is a fuel-sensing enzyme present in most mammalian tissue. In response to a decrease in the energy state of a cell AMPK is phosphorylated and activated by still poorly characterized upstream events. Exposure of bovine aortic endothelial cells (BAEC) to chemically synthesized ONOO- acutely and significantly increased phosphorylation of c-Src, PDK1, AMPK, and its downstream target, acetyl-CoA carboxylase (ACC), without affecting cellular AMP. This novel pathway for AMPK activation was confirmed by the use of pharmacological inhibitors and dominant-negative mutants. Exposure of BAEC to hypoxia-reoxygenation (H/R) caused a biphasic increase in AMPK and ACC phosphorylation, which was prevented by adenoviral overexpression of superoxide dismutase (SOD) or inhibition of nitric-oxide synthase (NOS) implicating a role of ONOO- formed during H/R. Furthermore, dominant-negative mutants of c-Src or kinase-defective PDK1 also blocked H/R-induced AMPK activation indicating that, as with addition of exogenous ONOO-, both c-Src and PI 3-kinase are upstream of AMPK. Moreover, H/R, like ONOO-, significantly increased co-immunoprecipitation of AMPK with c-Src, suggesting that ONOO- favors physical association of AMPK with upstream kinases. Taken together, our results indicate a novel pathway by which H/R via ONOO- activates AMPK in a c-Src-mediated, PI 3-kinase-dependent manner, and suggest that ONOO--induced activation of AMPK might thereby regulate metabolic enzymes, such as ACC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824177     DOI: 10.1074/jbc.M300215200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  A novel AMPK activator from Chinese herb medicine and ischemia phosphorylate the cardiac transcription factor FOXO3.

Authors:  Jingying Wang; Heng Ma; Xiaoyu Zhang; Leilei He; Jianming Wu; Xiaoping Gao; Jun Ren; Ji Li
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2009-03-25

Review 2.  Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.

Authors:  Biplab Dasgupta; Rishi Raj Chhipa
Journal:  Trends Pharmacol Sci       Date:  2015-12-20       Impact factor: 14.819

3.  Deletion of PRKAA triggers mitochondrial fission by inhibiting the autophagy-dependent degradation of DNM1L.

Authors:  Qilong Wang; Shengnan Wu; Huaiping Zhu; Ye Ding; Xiaoyan Dai; Changhan Ouyang; Young-Min Han; Zhonglin Xie; Ming-Hui Zou
Journal:  Autophagy       Date:  2017-01-13       Impact factor: 16.016

4.  Selective Ah receptor ligands mediate enhanced SREBP1 proteolysis to restrict lipogenesis in sebocytes.

Authors:  Gulsum E Muku; Nicholas Blazanin; Fangcong Dong; Philip B Smith; Diane Thiboutot; Krishne Gowda; Shantu Amin; Iain A Murray; Gary H Perdew
Journal:  Toxicol Sci       Date:  2019-06-21       Impact factor: 4.849

Review 5.  Alcoholic-induced hepatic steatosis--role of ceramide and protein phosphatase 2A.

Authors:  Rodjawan Supakul; Suthat Liangpunsakul
Journal:  Transl Res       Date:  2011-04-20       Impact factor: 7.012

6.  Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase.

Authors:  Suthat Liangpunsakul; Sung-Eun Wou; Kevin D Wineinger; Yan Zeng; Izabela Cyganek; Hiremagalur N Jayaram; David W Crabb
Journal:  Arch Biochem Biophys       Date:  2009-02-21       Impact factor: 4.013

7.  Phosphoinositide-dependent kinase-1 and protein kinase Cδ contribute to endothelin-1 constriction and elevated blood pressure in intermittent hypoxia.

Authors:  Bradley R Webster; Jessica M Osmond; Daniel A Paredes; Xavier A DeLeon; Olan Jackson-Weaver; Benjimen R Walker; Nancy L Kanagy
Journal:  J Pharmacol Exp Ther       Date:  2012-10-23       Impact factor: 4.030

8.  GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy.

Authors:  Mihwa Kim; Ji-Yeon Jung; Seungho Choi; Hyunseung Lee; Liza D Morales; Jeong-Tae Koh; Sun Hun Kim; Yoo-Duk Choi; Chan Choi; Thomas J Slaga; Won Jae Kim; Dae Joon Kim
Journal:  Autophagy       Date:  2016-10-18       Impact factor: 16.016

Review 9.  Effects of AMP-activated protein kinase in cerebral ischemia.

Authors:  Jun Li; Louise D McCullough
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-16       Impact factor: 6.200

10.  Activated protein C: a potential cardioprotective factor against ischemic injury during ischemia/reperfusion.

Authors:  Jingying Wang; Ji Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.